Breaking News Instant updates and real-time market news.

FDX

FedEx

$255.80

0.33 (0.13%)

09:18
09/18/18
09/18
09:18
09/18/18
09:18

FedEx price target raised to $318 from $310 at Loop Capital

Loop Capital analyst Rick Paterson raised his price target on FedEx to $318 after its Q1 results, saying the earnings miss was mainly due to wage increases that followed last year's tax cut legislation. The analyst adds that while FedEx raised its FY19 earnings guidance, its operating margins in Q1 were also lower as a result of higher hourly pay rates. Paterson remains positive on the stock and keeps his Buy rating, noting that the management's reaffirmation of expected operating profit improvement of $1.2B-$1.5B for its Express division in FY20 was particularly important for investor sentiment.

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

  • 03

    Oct

FDX FedEx
$255.80

0.33 (0.13%)

09/18/18
OPCO
09/18/18
NO CHANGE
Target $288
OPCO
Outperform
Oppenheimer says 'buy the dip' at FedEx following 'mixed' Q1 results
Oppenheimer analyst Scott Schneeburger maintained an Outperform rating and $288 price target on FedEx following the company's "mixed" quarterly results, telling investors in a research note to "buy the dip." Despite the softer start, FedEx maintained its FY19 revenue growth guidance and increased its adjusted EPS range and Schneeburger anticipates a strong peak season and broad-based second half of 2019-2020 lift.
09/18/18
COWN
09/18/18
NO CHANGE
Target $280
COWN
Outperform
FedEx weakness a buying opportunity, says Cowen
Cowen analyst Helane Becker noted FedEx shares were weak in the aftermarket following Q1 earnings that were below expectations. The analyst said she would use the weakness as a buying opportunity as management raised the full-year earnings range due to a strong economy and continued traction with revenue and cost initiatives. Becker reiterated her Outperform rating and $280 price target on FedEx shares.
09/18/18
FBCO
09/18/18
NO CHANGE
Target $307
FBCO
Outperform
FedEx price target cut to $307 from $315 at Credit Suisse
Credit Suisse analyst Allison Landry maintained an Outperform rating on FedEx but cut her price target to $307 from $315 following the company's weaker Q1 operating results. In a research note to investors, Landry says that although expectations "weren't high," the Q1 EBIT shortfall and the "low-quality" FY guidance should be enough to be met with a negative reaction from investors, but expects "modest" pressure on the stock today as FY top line and EBIT margins were reiterated. Landry says she "wasn't thrilled" with the results, but thinks there is merit to what CEO Fred Smith pointed out that quarterly earnings don't tell the whole story.
09/18/18
MSCO
09/18/18
NO CHANGE
Target $242
MSCO
Equal Weight
FedEx's 'big miss' in Q1 raises stakes for rest of year, says Morgan Stanley
Morgan Stanley analyst Ravi Shanker said FedEx's "big miss" in Q1 EPS was not purely cost-driven, as weaker pricing drove a revenue miss compared to his expectations. Despite the Q1 miss, FedEx raised its full-year EPS guidance due to "rounding," but Shanker sees pressure on the coming quarters' results and said the Q1 report raises the stakes for the remainder of the year. He lowered his price target on FedEx shares to $242 from $245 following the report and keeps an Equal Weight rating on the stock.

TODAY'S FREE FLY STORIES

YRD

Yirendai

$15.47

-1.75 (-10.16%)

17:01
11/12/18
11/12
17:01
11/12/18
17:01
Earnings
Yirendai reports Q3 adjusted income per ADS 87c, consensus 52c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

LTM

Latam Airlines

$8.96

-0.39 (-4.17%)

17:00
11/12/18
11/12
17:00
11/12/18
17:00
Hot Stocks
Latam Airlines reports October passenger traffic up 1.5% »

LATAM Airlines Group …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

ETON

Eton Pharmaceuticals

$0.00

(0.00%)

16:53
11/12/18
11/12
16:53
11/12/18
16:53
Syndicate
Eton Pharmaceuticals 3.6M share IPO priced at $6.00 »

National Securities acted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENR

Energizer

$60.18

-1.235 (-2.01%)

16:49
11/12/18
11/12
16:49
11/12/18
16:49
Hot Stocks
Energizer names Patrick Moore chairman of the board »

Energizer Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ACIU

AC Immune

$8.74

0.01 (0.11%)

16:47
11/12/18
11/12
16:47
11/12/18
16:47
Initiation
AC Immune initiated  »

AC Immune initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRNT

Kornit Digital

$19.15

-0.88 (-4.39%)

16:47
11/12/18
11/12
16:47
11/12/18
16:47
Earnings
Kornit Digital reports Q3 adjusted EPS 13c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ZGNX

Zogenix

$40.82

0.05 (0.12%)

16:46
11/12/18
11/12
16:46
11/12/18
16:46
Initiation
Zogenix initiated  »

Zogenix initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ADMS

Adamas Pharmaceuticals

$11.45

-0.455 (-3.82%)

16:45
11/12/18
11/12
16:45
11/12/18
16:45
Initiation
Adamas Pharmaceuticals initiated  »

Adamas Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 27

    Nov

  • 27

    Nov

AGN

Allergan

$163.82

-1.77 (-1.07%)

16:45
11/12/18
11/12
16:45
11/12/18
16:45
Initiation
Allergan initiated  »

Allergan initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

SAGE

Sage Therapeutics

$121.50

-9.46 (-7.22%)

16:45
11/12/18
11/12
16:45
11/12/18
16:45
Initiation
Sage Therapeutics initiated  »

Sage Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 27

    Nov

  • 19

    Dec

NBIX

Neurocrine

$103.03

-2.18 (-2.07%)

16:44
11/12/18
11/12
16:44
11/12/18
16:44
Initiation
Neurocrine initiated  »

Neurocrine initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

HLUYY

Lundbeck

$0.00

(0.00%)

16:44
11/12/18
11/12
16:44
11/12/18
16:44
Initiation
Lundbeck initiated  »

Lundbeck initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWPH

GW Pharmaceuticals

$134.48

-3.3 (-2.40%)

16:43
11/12/18
11/12
16:43
11/12/18
16:43
Initiation
GW Pharmaceuticals initiated  »

GW Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

BHVN

Biohaven Pharmaceutical

$36.42

-2.47 (-6.35%)

16:42
11/12/18
11/12
16:42
11/12/18
16:42
Initiation
Biohaven Pharmaceutical initiated  »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 14

    Nov

  • 27

    Nov

ACAD

Acadia

$18.86

-0.01 (-0.05%)

16:42
11/12/18
11/12
16:42
11/12/18
16:42
Initiation
Acadia initiated  »

Acadia initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ALKS

Alkermes

$34.70

-2.98 (-7.91%)

16:41
11/12/18
11/12
16:41
11/12/18
16:41
Initiation
Alkermes initiated  »

Alkermes initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 14

    Nov

  • 31

    Jan

GATX

GATX

$76.43

-2.54 (-3.22%)

16:37
11/12/18
11/12
16:37
11/12/18
16:37
Hot Stocks
GATX acquires up to 3,100 railcars for $229M »

GATX Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVGS

Navigator Holdings

$12.03

-0.13 (-1.07%)

16:35
11/12/18
11/12
16:35
11/12/18
16:35
Earnings
Navigator Holdings reports Q3 EPS 1c, consensus (2c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

GRA

W.R. Grace

$63.83

-0.705 (-1.09%)

16:35
11/12/18
11/12
16:35
11/12/18
16:35
Hot Stocks
W.R. Grace to increase price for silica-based, molecular sieve products by 7% »

W. R. Grace will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQH

AXA Equitable

$21.09

-0.355 (-1.66%)

16:34
11/12/18
11/12
16:34
11/12/18
16:34
Hot Stocks
AXA Equitable reports Q3 annualized premiums up 2% »

Reports Q3 operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

EQH

AXA Equitable

$21.09

-0.355 (-1.66%)

16:33
11/12/18
11/12
16:33
11/12/18
16:33
Hot Stocks
Breaking Hot Stocks news story on AXA Equitable »

AXA Equitable announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

EQH

AXA Equitable

$21.09

-0.355 (-1.66%)

16:32
11/12/18
11/12
16:32
11/12/18
16:32
Earnings
AXA Equitable reports Q3 adjusted EPS $1.23, consensus 91c »

Reports Q3 revenue $1.08B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

HAL

Halliburton

$34.17

-0.81 (-2.32%)

16:31
11/12/18
11/12
16:31
11/12/18
16:31
Hot Stocks
Halliburton names Lance Loeffler as CFO, Chris Weber to leave company »

Halliburton is pleased to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELVT

Elevate Credit

$4.11

-0.08 (-1.91%)

16:31
11/12/18
11/12
16:31
11/12/18
16:31
Hot Stocks
Elevate Credit appoints David Peterson Chief Credit Officer »

Elevate Credit announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROP

Roper Technologies

$289.16

-7.67 (-2.58%)

16:31
11/12/18
11/12
16:31
11/12/18
16:31
Hot Stocks
Roper Technologies raises quarterly dividend 12% to 46.25c per share »

Roper Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.